Paul Sorajja MD

Interventional Cardiology

Associate Director, Banner University Medicine Heart Institute Director, Interventional Cardiology and Structural Heart Disease, Banner University Medical Center - Phoenix Medical Director, Cardiac Cath Laboratory Lentsch Family Endowed Chair for Valve and Structural Heart Disease Professor of Medicine, University of Arizona College of Medicine

Join to view full profile

755 E McDowell RdFloor 4Phoenix, AZ 85006
Phone+1 602-521-3090
Fax+1 602-521-3661

Dr. Sorajja is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sorajja's full profile Already have an account?

Summary

Dr. Paul Sorajja is a cardiologist in Phoenix, AZ, and is affiliated with Banner University Medical Center - Phoenix. He received his medical degree from Mayo Clinic School of Medicine and has been in practice over 25 years. He specializes in interventional cardiology, hypertrophic cardiomyopathy, structural heart therapy, and valvular heart disease.

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Interventional Cardiology, 2004 - 2006
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 2001 - 2005
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2000 - 2001
Mayo Clinic College of MedicineClass of 1997

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

AZ State Medical License 2025 - 2028
MN State Medical License 1998 - 2026
FL State Medical License 2010 - 2015
LA State Medical License 2014 - 2014
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2013-2017
CMS Meaningful Use Stage 1 Certification Centricity Enterprise, GE Healthcare, 2013-2017
CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2013-2017

Clinical Trials

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
ACTIVE_NOT_RECRUITING
NA
Portico Next Generation Approval Study Start of enrollment: 2019 Sep 17
ACTIVE_NOT_RECRUITING
NA
MitraClip REPAIR MR Study Start of enrollment: 2020 Jul 21
ACTIVE_NOT_RECRUITING
NA

Publications & Presentations

PubMed

Clinical Outcomes of Transfemoral Transcatheter Mitral Valve Replacement: Results From the CHOICE-MI Registry.
Lena Strotmann, Andrea Scotti, Augustin Coisne, Adrian Heinze, Lukas Stolz
JACC. Cardiovascular Interventions. 2026-08-10
Age and Procedural Timing for Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR Trial.
Kashish Goel, Brian R Lindman, Allan Schwartz, David J Cohen, Gennaro Giustino
Circulation. Cardiovascular Interventions. 2026-08-01
Association between Cardiac MRI-derived Global Longitudinal Strain and Clinical Outcomes in Chronic Aortic Regurgitation.
Go Hashimoto, Maurice Enriquez-Sarano, Hideki Koike, Miho Fukui, Larissa I Stanberry
Radiology. Cardiothoracic Imaging. 2026-08-01

Journal Articles

Atrial Shunting for Heart Failure
Peter M Eckman, Paul Sorajja, Michael A Samara, ScienceDirect
Original Investigation Editorial Comment Searching for Surgical Alternatives in Hypertrophic Cardiomyopathy∗
William T Katsiyiannis, Paul Sorajja, Kevin M Harris, ScienceDirect
Prevalence, Trends, and Outcomes of Higher Risk Percutaneous Coronary Interventions Among Patients Without Acute Coronary Syndromes☆☆☆
Ivan Chavez, M Nicholas Burke, Daniel Lips, Jay Traverse, Emmanouil S Brilakis, Anil Poulose, Michael Mooney, Paul Sorajja, Yale Wang, ScienceDirect

Lectures

Once TMVR Is Refined, It Will Be the Preferred Therapy for Most MR Patients
CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/14/2019

Other

Searching for Surgical Alternatives in Hypertrophic Cardiomyopathy
Paul Sorajja, MD, JACC: Cardiovascular Imaging
https://www.doximity.com/articles/7753abf6-8311-4177-8f60-04b04b5d00d8
UpToDate, Wolters Kluwer Health - 2013-03-18

Authored Content

Hemodynamic Profiles and Clinical Response to Transcatheter Mitral RepairAugust 2022
Searching for Surgical Alternatives in Hypertrophic CardiomyopathyOctober 2018
1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular CalcificationApril 2018

Press Mentions

Banner Health Transforms Cardiac Care with First-In-Nation ProcedureJuly 9th, 2026
Real-World TriClip Data Show Reduced TR, Good Procedural SuccessJuly 1st, 2026
Banner Health Performs 1st US Mitral Valve Repair ImplantFebruary 2nd, 2026